Up­dat­ed: Sick­le cell gene edit­ing start­up halts tri­al af­ter flag­ging se­ri­ous side ef­fect in first pa­tient

The first-ever pa­tient to be treat­ed with a new, gene-edit­ed stem cell ther­a­py be­ing de­vel­oped for sick­le cell dis­ease ex­pe­ri­enced a se­ri­ous side ef­fect, forc­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER